Induction of sister chromatid exchanges by inhibitors of topoisomerases

Meesun Lim, Leroy-Fong Liu, David Jacobson-Kram, Jerry R. Williams

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

To investigate the role of topoisomerases in the production of sister chromatid exchanges, the effects of inhibitors of type I and II topoisomerases on baseline and mutagen-induced sister chromatid exchanges were compared. V79 cells were treated with VM-26 and m-AMSA, known inhibitors of type II topoisomerase, or with camptothecin, the only known inhibitor of type I topoisomerase. We observed that inhibitors of both type I and II topoisomerases induced high levels of sister chromatid exchanges at 10-6 M, and that the dose-response curves of these drugs were very similar. A clear heterogeneity in the distribution patterns of exchanges induced by inhibitors of topoisomerases was observed. We believe that this heterogeneity in response to these compounds is due to variation in sensitivity within the cell cycle. We also studied interactions of these agents with mitomycin-C and with PUVA (8-methoxypsoralen + UVA), both cross-linking agents and potent sister chromatid exchange inducers, and with x-rays, an agent that induces high levels of DNA strand breaks. No significant change in exchange levels was observed in interactions between topoisomerase inhibition and the levels induced by the agents studied. We conclude that double-strand break prevalence, known to be increased through inhibition of type II topoisomerase, is not the primary mechanism for induction of sister chromatid exchanges. We further conclude that acute inhibition of type I and type II topoisomerases does not influence substantially the induction of exchanges by other agents.

Original languageEnglish
Pages (from-to)485-494
Number of pages10
JournalCell Biology and Toxicology
Volume2
Issue number4
DOIs
Publication statusPublished - Dec 1986
Externally publishedYes

Fingerprint

Topoisomerase Inhibitors
Sister Chromatid Exchange
Topoisomerase I Inhibitors
Topoisomerase II Inhibitors
Type II DNA Topoisomerase
Amsacrine
Teniposide
Methoxsalen
Camptothecin
Type I DNA Topoisomerase
DNA Breaks
Mutagens
Mitomycin
Cell Cycle
Cells
X-Rays
X rays
DNA
Pharmaceutical Preparations

Keywords

  • camptothecin
  • m-AMSA
  • sister chromatid exchange
  • topoisomerase
  • VM-26

ASJC Scopus subject areas

  • Toxicology
  • Cell Biology

Cite this

Induction of sister chromatid exchanges by inhibitors of topoisomerases. / Lim, Meesun; Liu, Leroy-Fong; Jacobson-Kram, David; Williams, Jerry R.

In: Cell Biology and Toxicology, Vol. 2, No. 4, 12.1986, p. 485-494.

Research output: Contribution to journalArticle

Lim, Meesun ; Liu, Leroy-Fong ; Jacobson-Kram, David ; Williams, Jerry R. / Induction of sister chromatid exchanges by inhibitors of topoisomerases. In: Cell Biology and Toxicology. 1986 ; Vol. 2, No. 4. pp. 485-494.
@article{fa17e7583d5d4efcba33b7bd40ede00a,
title = "Induction of sister chromatid exchanges by inhibitors of topoisomerases",
abstract = "To investigate the role of topoisomerases in the production of sister chromatid exchanges, the effects of inhibitors of type I and II topoisomerases on baseline and mutagen-induced sister chromatid exchanges were compared. V79 cells were treated with VM-26 and m-AMSA, known inhibitors of type II topoisomerase, or with camptothecin, the only known inhibitor of type I topoisomerase. We observed that inhibitors of both type I and II topoisomerases induced high levels of sister chromatid exchanges at 10-6 M, and that the dose-response curves of these drugs were very similar. A clear heterogeneity in the distribution patterns of exchanges induced by inhibitors of topoisomerases was observed. We believe that this heterogeneity in response to these compounds is due to variation in sensitivity within the cell cycle. We also studied interactions of these agents with mitomycin-C and with PUVA (8-methoxypsoralen + UVA), both cross-linking agents and potent sister chromatid exchange inducers, and with x-rays, an agent that induces high levels of DNA strand breaks. No significant change in exchange levels was observed in interactions between topoisomerase inhibition and the levels induced by the agents studied. We conclude that double-strand break prevalence, known to be increased through inhibition of type II topoisomerase, is not the primary mechanism for induction of sister chromatid exchanges. We further conclude that acute inhibition of type I and type II topoisomerases does not influence substantially the induction of exchanges by other agents.",
keywords = "camptothecin, m-AMSA, sister chromatid exchange, topoisomerase, VM-26",
author = "Meesun Lim and Leroy-Fong Liu and David Jacobson-Kram and Williams, {Jerry R.}",
year = "1986",
month = "12",
doi = "10.1007/BF00117850",
language = "English",
volume = "2",
pages = "485--494",
journal = "Cell Biology and Toxicology",
issn = "0742-2091",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Induction of sister chromatid exchanges by inhibitors of topoisomerases

AU - Lim, Meesun

AU - Liu, Leroy-Fong

AU - Jacobson-Kram, David

AU - Williams, Jerry R.

PY - 1986/12

Y1 - 1986/12

N2 - To investigate the role of topoisomerases in the production of sister chromatid exchanges, the effects of inhibitors of type I and II topoisomerases on baseline and mutagen-induced sister chromatid exchanges were compared. V79 cells were treated with VM-26 and m-AMSA, known inhibitors of type II topoisomerase, or with camptothecin, the only known inhibitor of type I topoisomerase. We observed that inhibitors of both type I and II topoisomerases induced high levels of sister chromatid exchanges at 10-6 M, and that the dose-response curves of these drugs were very similar. A clear heterogeneity in the distribution patterns of exchanges induced by inhibitors of topoisomerases was observed. We believe that this heterogeneity in response to these compounds is due to variation in sensitivity within the cell cycle. We also studied interactions of these agents with mitomycin-C and with PUVA (8-methoxypsoralen + UVA), both cross-linking agents and potent sister chromatid exchange inducers, and with x-rays, an agent that induces high levels of DNA strand breaks. No significant change in exchange levels was observed in interactions between topoisomerase inhibition and the levels induced by the agents studied. We conclude that double-strand break prevalence, known to be increased through inhibition of type II topoisomerase, is not the primary mechanism for induction of sister chromatid exchanges. We further conclude that acute inhibition of type I and type II topoisomerases does not influence substantially the induction of exchanges by other agents.

AB - To investigate the role of topoisomerases in the production of sister chromatid exchanges, the effects of inhibitors of type I and II topoisomerases on baseline and mutagen-induced sister chromatid exchanges were compared. V79 cells were treated with VM-26 and m-AMSA, known inhibitors of type II topoisomerase, or with camptothecin, the only known inhibitor of type I topoisomerase. We observed that inhibitors of both type I and II topoisomerases induced high levels of sister chromatid exchanges at 10-6 M, and that the dose-response curves of these drugs were very similar. A clear heterogeneity in the distribution patterns of exchanges induced by inhibitors of topoisomerases was observed. We believe that this heterogeneity in response to these compounds is due to variation in sensitivity within the cell cycle. We also studied interactions of these agents with mitomycin-C and with PUVA (8-methoxypsoralen + UVA), both cross-linking agents and potent sister chromatid exchange inducers, and with x-rays, an agent that induces high levels of DNA strand breaks. No significant change in exchange levels was observed in interactions between topoisomerase inhibition and the levels induced by the agents studied. We conclude that double-strand break prevalence, known to be increased through inhibition of type II topoisomerase, is not the primary mechanism for induction of sister chromatid exchanges. We further conclude that acute inhibition of type I and type II topoisomerases does not influence substantially the induction of exchanges by other agents.

KW - camptothecin

KW - m-AMSA

KW - sister chromatid exchange

KW - topoisomerase

KW - VM-26

UR - http://www.scopus.com/inward/record.url?scp=0023006294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023006294&partnerID=8YFLogxK

U2 - 10.1007/BF00117850

DO - 10.1007/BF00117850

M3 - Article

VL - 2

SP - 485

EP - 494

JO - Cell Biology and Toxicology

JF - Cell Biology and Toxicology

SN - 0742-2091

IS - 4

ER -